<DOC>
	<DOCNO>NCT01204723</DOCNO>
	<brief_summary>The primary objective application test neurobehavioral mechanism effect aprepitant new cessation agent cannabis , tobacco .</brief_summary>
	<brief_title>Medications Development Treatment Cannabis Related Disorders</brief_title>
	<detailed_description>Stress ( emotional , physical , social ) facilitate drug seek behavior activation HPA axis , autonomic nervous system , brain DA system . Furthermore , alteration within several neuropeptide system ( CRF , Substance P , others ) also contribute role stress addiction . Central project anxiety stress response modulate substance P prefer target , NK1 receptor . Therefore aim pilot clinical trial determine safety efficacy aprepitant ( neurokinin 1 ( NK1 ) receptor antagonist ) . We hypothesize NK1 receptor antagonist , aprepitant , safe , tolerable efficacious reduce withdrawal symptom , cue craving , reinforcement value cannabis tobacco result cessation either drug . We assess hypothesis context carefully control human laboratory study subject ( N=72 ) randomize 3 x 2 factorial design one 3 behavioral condition ; ) withdrawn substance , b ) withdrawn tobacco , c ) withdrawn cannabis , receive one 2 medication dose condition : placebo aprepitant ( 160 mg/day ) . Medication administer 5 day , follow cue challenge , choice procedure , consequence ( i.e. , oral cannabis cigarette money ) also day 5 .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Peripheral Nervous System Agents</mesh_term>
	<mesh_term>Molecular Mechanisms Pharmacological Action</mesh_term>
	<criteria>Must meet DSMIV/ICD10 criterion cannabis abuse dependence Must nontreatment seek individual Participant meet DSMIV criterion current ( i.e. , criterion meet point past 30 day ) dependence substance alcohol , nicotine , caffeine , marijuana physiological dependence alcohol require medical detoxification . No subject trouble read English language visual hearing problem may interfere collection data Not currently take medication ( exception oral contraceptive ) would preclude safe participation study Must test negative pregnancy prior inclusion female use birth control pill must agree use condom intercourse 1 month participation study study medication decrease effectiveness birth control pill render ineffective Should general good health No evidence recent use illicit drug urine toxicity screen prior admission Major current ( within last 90 day ) Axis I psychopathology ( e.g. , major depressive disorder , bipolar disorder , schizophrenia ) Presence significant medical illness ( e.g. , diabetes , cardiovascular disease , hypertension , cancer , epilepsy , kidney disease ) Current , repeat illicit drug use ( marijuana ) Subject breastfeed pregnant Concurrent therapy drug know inhibit CYP3A4 activity Request drug treatment Current parole probation Recent history significant violent suicide behavior Allergic sesame oil</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Marijuana Abuse</keyword>
	<keyword>Nicotine Dependence</keyword>
	<keyword>Nicotine Withdrawal</keyword>
	<keyword>neurokinin Receptor</keyword>
	<keyword>NK1 Receptor antagonist</keyword>
	<keyword>Substance P</keyword>
	<keyword>Recurrence</keyword>
	<keyword>Substance Withdrawal Syndrome</keyword>
	<keyword>Substance-Related Disorders</keyword>
	<keyword>Disorders Environmental Origin</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Disease Attributes</keyword>
	<keyword>Pathologic Processes</keyword>
	<keyword>Tetrahydrocannabinol</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Psychotropic Drugs</keyword>
	<keyword>Analgesics , Non-Narcotic</keyword>
	<keyword>Analgesics</keyword>
	<keyword>Sensory System Agents</keyword>
	<keyword>Peripheral Nervous System Agents</keyword>
	<keyword>Neurotransmitter Agents</keyword>
	<keyword>Molecular Mechanisms Pharmacological Action</keyword>
	<keyword>Narcotic Antagonists</keyword>
	<keyword>cannabis</keyword>
</DOC>